Trials / Completed
CompletedNCT01955343
Immune Response in Lung Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Lithuanian University of Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate the importance of the immune cells localization (distribution) between malignant tumor islets and surrounding stroma and to investigate the associations between these immune cells as well as cytokines and clinicopathological and prognostic factors of non-small cell lung cancer (NSCLC) patients.
Conditions
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2015-07-01
- Completion
- 2016-03-01
- First posted
- 2013-10-07
- Last updated
- 2017-06-23
Locations
1 site across 1 country: Lithuania
Source: ClinicalTrials.gov record NCT01955343. Inclusion in this directory is not an endorsement.